Humer Franz B
SEC insider (Form 3/4/5 filer). CIK 0001548072. Director at Allogene Therapeutics, Inc. (ALLO). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Humer Franz B has filed insider reports for
- Allogene Therapeutics, Inc. (ALLO): Director
Humer Franz B
CIK: 0001548072
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALLO
Allogene Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 18, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
95.4K shares- - Jun 18, 2025ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
95.4K shares- - Dec 5, 2024ALLO
Allogene Therapeutics, Inc.
SaleDirect9.2K shares at avg. $2.16$20K
1-3 of 3 transactions